Connecticut officials announced the settlement with Mylan on Thursday. It resolves allegations that the pharmaceutical ...

Method-of-treatment (“MoT”) claims can be powerful tools for pharmaceutical companies seeking to extend market exclusivity for their products after the original composition-of-matter patents expire.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

(Reuters) - Mylan NV, which has come under fire for its drug pricing, said on Friday it would start selling a generic version of its life-saving EpiPen allergy treatment for $300 per two-pack, a more ...

Mylan Inc. and Mylan Pharmaceuticals Inc. v. SmithKline Beecham Corp. d/b/a GlaxoSmithKline, SmithKline Beecham P.L.C., SB Pharmco Puerto Rico Inc., Apotex Inc., and Apotex Corp., No.

(Reuters) - Mylan NV on Friday said it will pay $465 million to settle questions of whether it underpaid U.S. government healthcare programs by misclassifying its EpiPen emergency allergy treatment, ...

Apr. 1—MORGANTOWN — The WVU Innovation Corp. has officially taken ownership of the former Mylan pharmaceuticals plant on Chestnut Ridge Road, WVU announced on Thursday. Viatris — formed by the merger ...

The Federal Circuit reversed a Patent Trial and Appeal Board (“Board”) decision finding the challenged claims of Sanofi-Aventis’ ’614 patent unpatentable as obvious. Background Mylan petitioned for ...

Please provide your email address to receive an email when new articles are posted on . Mylan Pharmaceuticals has issued a voluntary recall of one batch of its 100 units/mL insulin glargine injection ...

(Reuters) - Pfizer Inc has agreed to spin off its off-patent branded drugs business and combine it with generic drugmaker Mylan NV, a move that leaves Pfizer with its more profitable innovative drugs, ...

Please provide your email address to receive an email when new articles are posted on . Mylan Pharmaceuticals, Inc. has announced a recall of one batch of its 100 units/mL insulin glargine injection ...

Mylan Pharmaceuticals’ manufacturing facility in Morgantown, WV, received an FDA Form 483 listing inspectional observations, some of which were due to failures of its quality control unit. Agency ...